Table 1. Malondialdehyde results.

	Group 1	Group 2	Group 3	Group 4	Group 1 vs. 3§	Group 1 vs. 4§
	Mean±SD	Mean±SD	Mean±SD	Mean±SD	Mean±SD	Mean±SD
Heart	46.9±16.4*	99.8±46.9	61.7±15.9†	62.6±23.8‡	<0.01	<0.05
Ischemic muscle	20.2±16.1**	58.1±16.4	40.4±10.1†	23.6±7.0‡‡‡	<0.01	>0.05
Kidney	30.5±12.2**	66.4±22.4	56.2±17.6	40.8±7.6‡‡	<0.01	>0.05
Liver	22.9±14.8**	63.4±33.8	43.1±17.3†	44.9±14.4‡	<0.05	<0.05
Blood	0.5±0.1*	0.6±0.0	0.5±0.0 †††	0.54±0.0‡‡‡	>0.05	>0.05
SD: Standard deviation; Passed the normality tests conducted using ANOVA and Tukey’s multiple comparison tests; Heart, ischemic muscle, kidney, liver (nmoL/100 mg protein), and blood (μmol/L) MDA levels. For paired comparison of sham with Groups 1, 3, and 4, p values are: Group 1 vs. Group 2: * <0.010; ** <0.001; Group 2 vs. Group 3: † <0.050; †† <0.010; ††† <0.001; Group 2 vs. Group 4: ‡ <0.050; ‡‡ <0.010; ‡‡‡ <0.001; (comparisons without notations are statistically not significant [p>0.05]). § P values. Group 1: Control group; Group 2: Sham group; Group 3: Clopidogrel pre-treatment group; Group 4: Rivaroxaban pre-treatment group.